Aydan Avdan Aslan

Dr. Aydan Avdan Aslan


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Academic Radiology
Verified
Journal Article
Closed access
AAAydan Avdan Aslan
Aydan Avdan Aslan
SGSerap Gültekin
Serap Gültekin
GYGüldal Esendağli Yilmaz
Güldal Esendağli Yilmaz
OKOsman Kurukahvecioğlu
Osman Kurukahvecioğlu

12 May 2023 in European Journal of Radiology
Verified
Journal Article
Closed access
AAAydan Avdan Aslan
Aydan Avdan Aslan
SGSerap Gültekin
Serap Gültekin

1 September 2021 in Clinical Imaging
Verified
Journal Article
Closed access
AAAydan Avdan Aslan
Aydan Avdan Aslan
GEGonca Erbaş
Gonca Erbaş
ZEZeynep Sezgi Erdal
Zeynep Sezgi Erdal
HŞHalit Nahit Şendur
Halit Nahit Şendur
MCMahi Nur Cerit
Mahi Nur Cerit
MAMehmet Araç
Mehmet Araç

21 November 2022 in Irish Journal of Medical Science (1971 -)
Verified
Journal Article
Closed access
PDF file
AAAydan Avdan Aslan
Aydan Avdan Aslan
SGSerap Gültekin
Serap Gültekin

7 March 2023 in Ultrasound Quarterly
Verified
Journal Article
Closed access
AAAydan Avdan Aslan
Aydan Avdan Aslan
SGSerap Gültekin
Serap Gültekin
MIMehmet Arda Inan
Mehmet Arda Inan
In this study, we aimed to investigate the correlation of stiffness values of shear-wave elastography (SWE) and histopathological prognostic factors in patients with breast cancer. Between January 2021 and June 2022, SWE images of 138 core-biopsy proven breast cancer lesions from 132 patients were retrospectively reviewed. Histopathogic prognostic factors, including tumor size, histologic grade, histologic type, hormone receptor positivity, human epidermal growth factor receptor (HER2) status, immunohistochemical subtype and Ki-67 index were documented. Elasticity values including mean and maximum elasticity (E mean and E max) and lesion-to-fat ratio (E ratio) were recorded. The association between histopathological prognostic factors and elasticity values were assessed using Mann-Whitney U and Kruskal-Wallis test, and multiple linear regression analysis. Tumor size, histological grade, and Ki-67 index were significantly associated with the E ratio (P < 0.05). Larger tumor size and higher Ki-67 index also showed significantly higher E mean and E max values (P < 0.05). However, hormone receptor positivity, HER2 status, and immunohistochemical subtype were not significantly associated with elasticity values (P > 0.05). Multivariate logistic regression analysis revealed that tumor size was significantly associated with E mean, E max, and E ratio values (P < 0.05). A high Ki-67 index was also significantly associated with high E ratio values. Larger tumor size and higher Ki-67 index are independently associated with high E ratio values. Preoperative SWE may improve the performance of conventional ultrasound in predicting prognosis and treatment planning.

19 August 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
HAHale Aydin
Hale Aydin
CBCansu Bozkurt
Cansu Bozkurt
İÖİrem Özcan
İrem Özcan
SHSerhat HAYME
Serhat HAYME
ABAlmıla Coşkun Bilge
Almıla Coşkun Bilge
ISIrmak Durur Subası
Irmak Durur Subası
Background/Objectives: Segmental non-mass enhancement (NME) is the breast MRI distribution pattern with the highest positive predictive value (PPV) for malignancy. Despite its diagnostic relevance, its imaging characteristics have rarely been examined in isolation, leaving uncertainty in clinical practice. This multicenter study aimed to evaluate multiparametric MRI features—including internal enhancement pattern, dynamic contrast enhancement (DCE) kinetics, and diffusion restriction—in segmental NME to identify malignancy predictors. Methods: This retrospective cohort reviewed 14,834 breast MRI reports from five institutions (September 2017–February 2024), identifying 103 women (mean age, 44.4 ± 9.9 years) with segmental NME (70 malignant, 33 benign). MRI was performed at 1.5T or 3T using standardized protocols. Two breast radiologists, blinded to pathology, assessed internal enhancement, DCE kinetics, diffusion restriction, and short tau inversion recovery (STIR) features according to BI-RADS. Statistical analyses included chi-square/Fisher’s tests and logistic regression. Results: Clustered ring enhancement (CRE) was significantly associated with malignancy (p = 0.004). Fast initial-phase enhancement (p < 0.001) and delayed-phase washout (p = 0.011) also correlated with malignancy. On multivariate analysis, fast initial-phase enhancement remained an independent predictor (odds ratio [OR] = 5.133, p = 0.031), whereas slow enhancement predicted benignity (OR = 0.194, p = 0.020). Histologies included ductal carcinoma in situ, invasive ductal carcinoma, granulomatous mastitis, and benign hyperplastic lesions. Conclusions: This study, focusing exclusively on segmental NME, identifies CRE, fast initial-phase enhancement, and washout kinetics as reliable imaging biomarkers. Incorporating these features into breast MRI interpretation may improve diagnostic accuracy, risk stratification, and management decisions.